Evidence map›Paper›PMID 37297760›Full record

ArticleHealthcare (Basel, Switzerland)2023

Primary PCI and Mental Health: A 12-Month Follow-Up Study.

Dragoș Vulcănescu, Veronica Gheorman, Daniel Cristian Pîrvu, Venera Cristina Dinescu, Victor Gheorman, Ion Udriștoiu, Alina Maria Paraschiv, Marius Gabriel Bunescu, Mihaela Corina Berceanu, Lavinia Gheorman and 5 more

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Dragoș VulcănescuDepartment of Psychiatry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Veronica GheormanDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.ORCID 0009-0006-8853-5238
Daniel Cristian PîrvuDepartment of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Venera Cristina DinescuDepartment of Health Promotion and Occupational Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Victor GheormanDepartment of Psychiatry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Ion UdriștoiuDepartment of Psychiatry, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Alina Maria ParaschivDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Marius Gabriel BunescuOccupational Medicine Department, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Mihaela Corina BerceanuDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Lavinia GheormanDepartment of Diabetology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Sorin Nicolae DinescuDepartment of Epidemiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Romeo PopaDepartment of Pharmacology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Cristina FlorescuDepartment of Cardiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
Adrian MităInternal Medicine Department, University of Medicine and Pharmacy of Craiova, Filantropia Hospital of Craiova, 200143 Craiova, Romania.ORCID 0000-0003-3153-1130
Cătălin Mircea ForțofoiuInternal Medicine Department, University of Medicine and Pharmacy of Craiova, Filantropia Hospital of Craiova, 200143 Craiova, Romania.ORCID 0000-0002-3341-1442
University of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The research article highlights the significance of acute myocardial infarction (AMI) and its impact on depression and anxiety among patients' post-primary percutaneous coronary interventions (PCI). The study aims to determine the frequency of depression and anxiety occurrence in patients with acute myocardial infarction after primary PCI. The objective of this study is to investigate the frequency of depression and anxiety in patients with acute myocardial infarction after primary PCI. The method used in the study involved the collection of data from 88 patients with acute myocardial infarction who underwent primary PCI treatment. The patients were tested before PCI and then at intervals of 1 month, 6 months, and 12 months post-PCI using the Hamilton Depression Scale (HAM-D17) and the Hamilton Anxiety Scale (HAM-A) to identify depression and anxiety symptoms, respectively. The study performed a comprehensive analysis of the collected data to determine the frequency of depression and anxiety occurrence in post-PCI patients. The study found evidence that primary PCI reduces depression and anxiety in patients who have experienced a myocardial infarction. However, mental health issues continue to be a significant psychological concern for patients post-PCI, impacting their lifestyle, self-care, and treatment adherence. The study suggests that healthcare providers should actively screen and manage psychiatric disorders in patients who have suffered from AMI as they are at an increased risk of mental disorders. In conclusion, the study indicates that depression and anxiety are common issues in acute myocardial infarction survivors, and interventions addressing these conditions should be a routine part of care. The study highlights the need for healthcare providers to be aware of the increased risk of mental disorders in individuals who have suffered from AMI. Understanding the impact of anxiety and depression on post-PCI patients is essential for the development of effective interventions that support patients' recovery.

Indexed as

anxietydepressionPCI

Identifiers

PMID37297760
PMCPMC10252455
OpenAlexW4379230711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.